Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma.

immunotherapy malignant pleural mesothelioma target therapy

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
25 May 2021
Historique:
received: 20 04 2021
revised: 09 05 2021
accepted: 18 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

Malignant pleural mesothelioma (MPM) is a rare malignancy characterized by very poor prognosis and lack of treatment options. Immunotherapy has rapidly emerged as an effective tool for MPM, particularly for tumors of non-epithelioid histology. At the same time, comprehensive genomic sequencing may open the way to new-generation targeted-drugs able to hit specific MPM molecular vulnerabilities. These innovations will possibly enrich, but also dramatically complicate, the elucidation of treatment algorithms. Multidisciplinary integration is urgently needed.

Identifiants

pubmed: 34070352
pii: jcm10112290
doi: 10.3390/jcm10112290
pmc: PMC8197557
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Clin Lung Cancer. 2021 Jan;22(1):e63-e66
pubmed: 32917522
J Thorac Oncol. 2008 Oct;3(10):1089-95
pubmed: 18827603
Lancet Oncol. 2019 Feb;20(2):239-253
pubmed: 30660609
Lancet Respir Med. 2019 Mar;7(3):260-270
pubmed: 30660511
Lung Cancer. 2009 Jan;63(1):94-7
pubmed: 18486273
Nature. 2012 Jan 29;482(7384):246-50
pubmed: 22286062
J Immunother Cancer. 2021 Feb;9(2):
pubmed: 33632900
J Clin Oncol. 2019 Oct 1;37(28):2537-2547
pubmed: 31386610
Cancer Res. 1994 Nov 1;54(21):5547-51
pubmed: 7923195
Cancer Cell. 2008 Mar;13(3):261-71
pubmed: 18328429
J Thorac Oncol. 2008 Jul;3(7):756-63
pubmed: 18594322
J Pathol. 2001 Apr;193(4):468-75
pubmed: 11276005
Nat Med. 2015 Nov;21(11):1344-9
pubmed: 26437366
Lancet. 2021 Jan 30;397(10272):375-386
pubmed: 33485464
Ann Oncol. 2015 Sep;26 Suppl 5:v31-9
pubmed: 26223247
Genes Chromosomes Cancer. 2015 Jan;54(1):51-62
pubmed: 25231345
Lancet. 2016 Apr 2;387(10026):1405-1414
pubmed: 26719230
J Biol Chem. 2016 Dec 23;291(52):26750-26761
pubmed: 27756837
Cancer Res. 2016 Jan 15;76(2):206-15
pubmed: 26719535
Arch Pathol Lab Med. 2018 Jan;142(1):89-108
pubmed: 28686500
Lancet Oncol. 2020 Sep;21(9):1213-1223
pubmed: 32888453
Int J Environ Res Public Health. 2018 May 16;15(5):
pubmed: 29772681
Lancet Oncol. 2017 Sep;18(9):1261-1273
pubmed: 28729154
Lancet Oncol. 2018 Jun;19(6):799-811
pubmed: 29753703
Lancet Oncol. 2017 May;18(5):623-630
pubmed: 28291584
Cancer. 1996 Apr 1;77(7):1379-85
pubmed: 8608519
J Thorac Oncol. 2013 Jun;8(6):783-7
pubmed: 23571475
Ann Oncol. 2020 Dec;31(12):1734-1745
pubmed: 32976938
Med Oncol. 2014 Aug;31(8):74
pubmed: 24958517
Lancet Respir Med. 2019 Jul;7(7):569-580
pubmed: 31103412
Lancet Oncol. 2015 Apr;16(4):447-56
pubmed: 25800891
Lancet Respir Med. 2021 Jun;9(6):613-621
pubmed: 33836153
Cancers (Basel). 2020 Oct 13;12(10):
pubmed: 33065998
J Thorac Oncol. 2012 Sep;7(9):1449-56
pubmed: 22895142
Lancet Oncol. 2013 Oct;14(11):1104-1111
pubmed: 24035405
J Thorac Oncol. 2020 May;15(5):843-859
pubmed: 32004714
Oncogene. 1998 Jun 18;16(24):3087-95
pubmed: 9671387
J Clin Oncol. 2003 Jul 15;21(14):2636-44
pubmed: 12860938
Ann Oncol. 2018 May 1;29(5):1258-1265
pubmed: 29514216
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):285-90
pubmed: 24347639
Nat Genet. 2016 Apr;48(4):407-16
pubmed: 26928227
Lancet Respir Med. 2015 Apr;3(4):301-9
pubmed: 25819643
J Clin Oncol. 2018 May 1;36(13):1343-1373
pubmed: 29346042
J Thorac Oncol. 2009 Jan;4(1):97-101
pubmed: 19096314
Nat Genet. 2011 Aug 28;43(10):1022-5
pubmed: 21874000
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Br J Cancer. 1999 Sep;81(1):54-61
pubmed: 10487612
Mol Cancer Ther. 2006 Dec;5(12):3085-95
pubmed: 17172411
Lung Cancer. 2011 Apr;72(1):73-7
pubmed: 21216487
Cancer. 2008 Apr 1;112(7):1555-61
pubmed: 18286536
Lancet Respir Med. 2021 Jun;9(6):593-600
pubmed: 33515503
Clin Cancer Res. 2019 Sep 15;25(18):5485-5492
pubmed: 31164373
J Thorac Oncol. 2018 Oct;13(10):1569-1576
pubmed: 29908324
Clin Cancer Res. 2020 Sep 15;26(18):4748-4755
pubmed: 32669375
Clin Cancer Res. 1999 Nov;5(11):3364-8
pubmed: 10589746
J Thorac Oncol. 2018 Jan;13(1):124-133
pubmed: 29079455
Cancer Discov. 2018 Dec;8(12):1548-1565
pubmed: 30322867
J Thorac Oncol. 2010 Oct;5(10):1655-61
pubmed: 20736856
JAMA Oncol. 2019 Mar 1;5(3):351-357
pubmed: 30605211
Lung Cancer. 2012 Mar;75(3):360-7
pubmed: 21937142
Lancet Respir Med. 2018 Jun;6(6):451-460
pubmed: 29773326
Cell Death Dis. 2013 Dec 12;4:e956
pubmed: 24336076

Auteurs

Emanuele Vita (E)

Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Roma, Italy.
Medical Oncology, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.

Alessio Stefani (A)

Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Roma, Italy.
Medical Oncology, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.

Mariantonietta Di Salvatore (M)

Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Roma, Italy.
Medical Oncology, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.

Marco Chiappetta (M)

Thoracy Surgery, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.

Filippo Lococo (F)

Thoracy Surgery, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.

Stefano Margaritora (S)

Thoracy Surgery, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.

Giampaolo Tortora (G)

Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Roma, Italy.
Medical Oncology, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.

Emilio Bria (E)

Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Roma, Italy.
Medical Oncology, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.

Classifications MeSH